Drug intelligence / Profile preview

Gualou Guanxin Heji

Development stage: Preclinical
Administration: Oral

Overview

Gualou Guanxin Heji (瓜蒌冠心合剂) is a Traditional Chinese Medicine (TCM) compound preparation primarily used for the treatment of coronary heart disease (CHD). It is named for its key ingredient, Gualou (Trichosanthes), and its indication for "Guanxin" (coronary heart) conditions. The preparation is understood to exert its therapeutic effects through multiple mechanisms, including vasodilation, improving myocardial blood flow, inhibiting platelet aggregation, enhancing cardiac function, and possessing anti-atherosclerotic properties. As a TCM formula, its action is often attributed to the synergistic effects of its various herbal components, aiming to alleviate symptoms such as chest pain and tightness associated with CHD.

Other names: 瓜蒌冠心合剂

Beyond the preview

Go deeper on Gualou Guanxin Heji.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gualou Guanxin Heji.

Explore the full profile